A capital injection is an infusion of cash or assets into a business from an outside investor or an existing owner, given in exchange for an ownership stake, a debt obligation, or a future claim on equity. The structure you pick decides who controls the company afterward, how profits are shared, what disclosures you owe regulators, and what tax bill (if any) the transaction generates. The mechanics fall into a handful of well-defined categories, and the differences between them matter well before the money changes hands.
How a Capital Injection Shows Up on the Balance Sheet
Every capital injection lands in one of two places. An equity injection increases the ownership section, recorded as common stock or paid-in capital. A debt injection increases the liability section, recorded as a loan or note payable. That distinction is not just accounting housekeeping. It drives borrowing capacity, tax position, and how much control existing owners keep.
The reason for the injection shapes the terms. A startup raising to build a product before it has revenue looks different from a mature company raising to acquire a competitor, which looks different again from a struggling business that needs cash to cover payroll while it restructures. Growth capital tends to come with equity dilution. Bridge financing for a cash crunch often takes the form of short-term debt with tight lender controls.
Equity, Debt, or Something in Between
Equity Injections
An equity injection means selling a piece of the company. The investor receives newly issued shares, which dilutes the percentage held by existing shareholders. If you owned 100% and sell 20%, you now own 80%. The upside for the company is that equity carries no fixed repayment obligation. The investor’s return depends entirely on the company’s success, whether through dividends, a sale, or an IPO. The downside is that equity investors want a say in how the business is run. They routinely negotiate for board seats, veto rights over major decisions like taking on debt or selling the company, and information rights that require regular financial reporting.
Early investors also almost always negotiate anti-dilution protections. These clauses adjust the early investor’s economics if the company later raises money at a lower valuation. A full ratchet resets the early investor’s conversion price to the new, lower price. A weighted average uses a formula that factors in both the old price and the number of new shares issued, producing a less dramatic adjustment. Founders typically push for weighted average because full ratchet can be punishing in a down round.
The standard legal package for a venture-backed equity injection includes a stock purchase agreement, a voting agreement, an investors’ rights agreement, and a right of first refusal and co-sale agreement.1National Venture Capital Association. NVCA Model Legal Documents A term sheet sets the key business terms first, but it is mostly non-binding except for its confidentiality and exclusivity provisions.
Debt Injections
A debt injection is a loan. The company gets capital now and agrees to repay it with interest on a fixed schedule. No ownership changes hands. For businesses with predictable cash flow, this is often the preferred structure because it preserves full control.
Lenders protect themselves through collateral and financial covenants. Collateral might include real estate, equipment, inventory, or accounts receivable. Covenants are ongoing performance tests the company must pass, such as maintaining a minimum ratio of earnings to debt payments or keeping total leverage below a threshold. Tripping a covenant can trigger default provisions that let the lender accelerate the loan or seize collateral, so these ratios matter long after closing day.
One of debt’s main advantages is that interest payments reduce taxable income. Federal tax law generally allows a deduction for interest on business indebtedness, but there is a ceiling. For most businesses, deductible business interest in any year cannot exceed business interest income plus 30% of adjusted taxable income.2Office of the Law Revision Counsel. 26 USC 163 – Interest Excess interest carries forward to future years. Small businesses with average annual gross receipts of $30 million or less over the prior three years are generally exempt from the limitation.3Internal Revenue Service. Questions and Answers About the Limitation on the Deduction for Business Interest Expense
Hybrid Instruments
Not every capital injection fits neatly into the equity or debt box. Two hybrids dominate early-stage financing because they let a company raise money without agreeing on a valuation upfront.
A convertible note starts as a loan. The investor lends money, the note accrues interest (typically 5% to 8% annually), and instead of being repaid in cash the note converts into equity when the company raises a larger funding round. Conversion usually happens at a discount to the price paid by new investors, commonly 15% to 25% off, rewarding the early investor for taking on more risk. A valuation cap sets a maximum company valuation for conversion, protecting the note holder if the company’s value jumps before the next round. If the note reaches its maturity date without converting, the company must repay principal plus interest or negotiate an extension.
A SAFE, or Simple Agreement for Future Equity, works similarly but is not debt. There is no interest rate, no maturity date, and no repayment obligation. The investor simply receives the right to convert into equity at a future financing event, usually at a discount or subject to a valuation cap. SAFEs do not appear as liabilities, and the company owes nothing back if the business fails. That is what makes them popular with very early-stage startups.
Mezzanine financing sits between traditional debt and equity for larger, established companies. It is subordinated debt: the lender gets repaid after senior lenders but before equity holders. The higher risk is compensated through above-market interest rates and an equity kicker, often warrants that let the mezzanine lender buy shares at a set price. Companies use mezzanine for acquisitions, expansions, or management buyouts when they want capital beyond what senior lenders will provide but do not want to give up a large equity stake.
Where the Capital Comes From
The source depends on the company’s size, stage, and risk profile. Internal sources include owners contributing personal funds as paid-in capital or shareholder loans, and retained earnings reinvested back into the business.
External sources sort by maturity. Angel investors typically fund very early-stage companies, often writing checks between $25,000 and $500,000 for equity. Venture capital firms invest larger amounts in high-growth startups, usually taking preferred stock with special rights. Private equity firms target mature companies and frequently take controlling stakes to drive operational changes. Commercial banks provide debt through term loans, revolving credit lines, or asset-backed lending. Strategic partners such as suppliers, distributors, or corporate customers sometimes invest in exchange for exclusive business arrangements or joint venture rights.
Equity crowdfunding has opened a newer path. Under Regulation Crowdfunding, a company can raise up to $5 million from the general public in any 12-month period through an SEC-registered funding portal.4U.S. Securities and Exchange Commission. Regulation Crowdfunding The disclosure and reporting obligations are significant relative to the amounts raised.
Securities Law When You Issue Equity
This catches many business owners off guard: issuing equity in exchange for capital is issuing a security, and securities are regulated by the SEC. Unless the company registers the offering, which is expensive and slow, it needs an exemption. Most private capital injections rely on Regulation D.
Rule 506(b) vs. Rule 506(c)
Two Regulation D pathways handle most private raises. Rule 506(b) allows unlimited capital without general solicitation, sold to unlimited accredited investors and up to 35 non-accredited investors in any 90-day period. Rule 506(c) allows general solicitation and advertising, but every purchaser must be accredited, and the company must take reasonable steps to verify their status rather than relying on their word.5U.S. Securities and Exchange Commission. Exempt Offerings
The difference matters. Under 506(b), you need only a reasonable belief that investors are accredited. Under 506(c), you must actively verify accredited status through documentation such as tax returns, bank statements, or written confirmation from a broker-dealer, investment adviser, attorney, or CPA. An investor checking a box on a form claiming they are accredited, with no other information, does not satisfy either standard.6U.S. Securities and Exchange Commission. Assessing Accredited Investors Under Regulation D
Who Qualifies as Accredited
An individual qualifies by meeting either a net worth test or an income test. The net worth threshold is over $1 million, individually or jointly with a spouse or partner, excluding the value of a primary residence. The income threshold is over $200,000 individually, or $300,000 jointly, in each of the prior two years with a reasonable expectation of the same in the current year.7U.S. Securities and Exchange Commission. Accredited Investors Certain professionals, including registered broker-dealers and investment advisers, also qualify regardless of personal finances.
Form D and State Filings
After selling securities under Regulation D, the company must file a Form D notice with the SEC no later than 15 calendar days after the first sale.8eCFR. 17 CFR 239.500 – Form D, Notice of Sales of Securities Most states also require a separate notice filing with their securities regulator, often called a blue sky filing, with fees that vary by state. Missing the deadline does not automatically void the federal exemption, but it creates enforcement risk, and some states treat late filings more seriously than the SEC does.
Tax Treatment
Tax consequences depend on whether the transaction is equity, debt, or a hybrid, and on the type of entity receiving the funds.
Section 351: Tax-Free Contributions to a Corporation
When one or more people transfer property (including cash) to a corporation solely in exchange for stock, and they collectively own at least 80% of the corporation’s voting power and total shares immediately after the exchange, no gain or loss is recognized.9Internal Revenue Service. Revenue Ruling 2003-51 – Section 351 Transfer to Corporation Controlled by Transferor This is what lets founders contribute assets to a new corporation without triggering a taxable event. It also applies to later capital contributions, provided the contributors collectively meet the 80% control threshold after the exchange. If the transferor receives anything other than stock, such as cash or debt relief, the non-stock portion may be taxable.
The Company’s Side: Section 118
Shareholder contributions to a corporation’s capital are generally excluded from the corporation’s gross income. The company owes no tax on money its owners put in. Contributions from non-shareholders, though, such as customers, government entities, or civic groups, are no longer excluded from income for most corporations. A narrow exception exists for regulated water and sewerage utilities that receive contributions in aid of construction.10Office of the Law Revision Counsel. 26 USC 118 – Contributions to the Capital of a Corporation
S Corporations: Track Basis From Day One
For S corporation shareholders, every capital contribution increases stock basis, which determines how much of the company’s losses and deductions the shareholder can claim on a personal return. The basis increase is reported on Line 2 of IRS Form 7203.11Internal Revenue Service. Instructions for Form 7203 – S Corporation Shareholder Stock and Debt Basis Limitations If basis runs out, losses are suspended until the shareholder makes additional contributions or loans. Keeping accurate basis records from the start avoids painful reconstruction at tax time.
Qualified Small Business Stock
Investors who acquire stock directly from a qualifying C corporation may be able to exclude 100% of their capital gains when they sell. To qualify, the stock must be held for at least five years, the corporation must use at least 80% of its assets in an active business, and the company’s gross assets must not exceed $75 million at the time the stock is issued (for stock issued after July 4, 2025; the prior $50 million threshold applies to earlier stock).12Office of the Law Revision Counsel. 26 USC 1202 – Partial Exclusion for Gain From Certain Small Business Stock The $75 million threshold is adjusted for inflation starting in 2027. S corporations, partnerships, and LLCs taxed as partnerships do not qualify, though an LLC that has elected C corporation tax treatment may. Certain industries, including financial services, hospitality, and professional services, are excluded.
Section 1244 Ordinary Loss Treatment
If the investment goes badly, Section 1244 offers a consolation. Shareholders of qualifying small businesses can treat losses on their stock as ordinary losses rather than capital losses, up to $50,000 per year ($100,000 on a joint return). Ordinary losses are more valuable because they offset all types of income, not just capital gains. To qualify, the corporation must have received no more than $1 million in total money and property for its stock at the time of issuance, and more than half of its gross receipts during the five years before the loss must have come from active business operations rather than passive sources like investments or royalties.13Office of the Law Revision Counsel. 26 USC 1244 – Losses on Small Business Stock
Getting the Deal Done
Preparation
The work that happens before you talk to an investor determines whether the conversation goes anywhere. Start with clean financial statements. Audited statements carry the most weight, but at minimum you need reviewed financials prepared by a CPA. Expect to provide at least three years of historical data, including balance sheet, income statement, and statement of cash flows. If you are newer than that, be prepared to defend your projections in granular detail.
You also need a clear use-of-funds plan. Investors do not hand over capital for vague intentions. Break down where the money goes: equipment, hiring, marketing, reserve. A detailed allocation signals discipline and lets the capital provider assess risk.
For equity raises, you will need a valuation. Early-stage companies often use comparable company analysis or recent transaction multiples. More mature companies may commission a discounted cash flow analysis. If you are issuing stock options alongside the capital injection, you may need a formal 409A valuation to set the exercise price. Professional 409A valuations typically cost between $1,500 and $9,000 depending on complexity. Corporate formation documents, operating agreements, existing contracts, intellectual property records, and prior cap tables should be organized before due diligence begins.
Term Sheet and Due Diligence
The process typically starts with a term sheet laying out the key economic and governance terms. For an equity deal, that includes valuation, the type of stock being issued, board composition, and liquidation preferences. For debt, it covers interest rate, repayment schedule, collateral, and covenants. The term sheet is a framework for negotiation, not a final agreement.
After the term sheet is signed, the investor’s legal and financial team runs due diligence: a comprehensive review of financial records, contracts, litigation history, tax filings, intellectual property, and regulatory compliance. It can take two weeks for a simple deal or several months for a complex one. Most deals either solidify or fall apart here.
Definitive Agreements and Closing
If due diligence goes well, the parties negotiate and execute the definitive legal agreements. For an equity deal, those include the stock purchase agreement and the governance documents. For a debt deal, the package includes a loan agreement, a promissory note, and a security agreement granting the lender a lien on pledged collateral. Once the funds transfer, the capital injection is complete and the ongoing obligations under the agreements begin.